CD34 PE-Cy7

Also known as: Mucosialin, Class III epitope

Clone: 4H11 (APG)

CE

SKU# 9025-0349

Cat. No. Size
9025-0349-025 25 tests
9025-0349-120 120 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for CD34 PE-Cy7.

Fluorescence profiles of normal human peripheral blood cells showing autofluorescence of unstained...View More

  • Data for CD34 PE-Cy7.
Description

Description: The 4H11 monoclonal antibody reacts with human CD34, also known as mucosialin. CD34 belongs to a protein family which also includes endoglycan and podocalyxin. Members of this family are single pass transmembrane proteins with a heavily glycosylated extracellular and N-terminal mucin domain. CD34 was first identified as an antigen expressed on hematopoietic progenitors, and has since been extensively used as a marker to isolate cells capable of hematopoietic cell engraftment. In spite of this, the function of CD34 remains unresolved. In addition to expression on hematopoietic progenitors, CD34 is expressed on some populations of mesenchymal stem cells, tumor cell lines, and by vascular endothelia in the adult. Epitopes of CD34 have been assigned to three classes (class I, II or III) based on their differential sensitivity to enzymatic cleavage by neuraminidase, chymopapain, or O-glycoprotease. According to this analysis, the 4H11 antibody belongs to class III, indicating that it reacts with a protein epitope.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate PE-Cyanine7
Laser Blue Laser
Emit 760 nm
Excite 488 nm
Legal For research (not to include in vivo research) and/or in vitro diagnostic use only. The only permitted commercial use is provision of research (not to include in vivo research) services and/or in vitro diagnostic services. Not for therapeutic or in vivo applications. Other use needs licenses which are available from GE Healthcare Bio-Sciences Corp. Under U.S. patent nos. Nos 5,268,486, 5,569,587 and 5,627,027 and foreign equivalents and pending applications. This product is subject to proprietary rights of GE Healthcare Bio-Sciences Corp. (“GE Healthcare”) and Carnegie Mellon University (“CMU”) and made and sold under license from GE Healthcare. The product bearing this label is licensed for sale only for research (not to include in vivo research) and in addition may be used to perform research (not to include in vivo research) and/or in vitro diagnostic services for third parties. It is not licensed nor are there any implied licenses for any other use including, without limitation, commercial uses unless expressly authorized by GE Healthcare in writing. If you intend to use this product commercially and you do not have a license to use this product for the intended commercial purpose, return this product, unopened to eBioscience, Inc. 10255 Science Center Drive, San Diego, California 92121 USA and any money paid for the product will be refunded.
Reported Applications Flow Cytometric Analysis
Documentation
Instructions for Use (English) Download English IFU
Instructions for Use (French) Download French IFU
Instructions for Use (German) Download German IFU
Instructions for Use (Italian) Download Italian IFU
Instructions for Use (Spanish) Download Spanish IFU
Additional Formats
Cat. No. Name Excite Emit Application Reg.
9012-0349 CD34 PE 488 nm 575 nm FC CE
9017-0349 CD34 APC 633 - 647 nm 660 nm FC CE
9011-0349 CD34 FITC 488 nm 518 nm FC CE
9046-0349 CD34 PerCP-eFluor® 710 488 nm 710 nm FC CE
9043-0349 CD34 PerCP 488 nm FC CE
References

References: Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture (H3-A6), 3rd Edition published by the National Committee for Clinical Laboratory Standards.

Sutherland DR, Watt SM, Dowden G, Karhi K, Baker MA, Greaves MF, Smart JE. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. Leukemia. 1988 Dec;2(12):793-803.

Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA. Binding of L-selectin to the vascular sialomucin CD34. Science. 1993 Oct 15;262(5132):436-8.